Answers are grounded in this paper and cite their sources.
Complex genetic counseling situations can arise when whole-gene sequencing is used as part of reproductive genetic carrier screening or newborn screening for cystic fibrosis (CF). One of the most common scenarios is when one reproductive partner carries a CF-causing variant such as c.1521-1523del (or p.F508del) and the other partner carries the c.1210-12T[5] (or IVS8-5T) variant. Questions arise as to what information to provide about the likely outcome if the fetus or newborn has both variants in trans, as well as implications for future pregnancies and other family members. In this paper, we consider an approach to genetic counseling based on knowledge of CFTR biology and available clinical data.
No takes yet. Share an insight, caveat, or question.
Massie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: